Recent Updates Page 2 RSS Back to NoCamels

  • mayay 3:58 pm on August 26, 2014 Permalink
    Tags: clinique israeli red algae, clinique red algae skin care, clinique smart custom repair serum, israeli red algae, red algae benefits, red algae skin care   

    Israel’s Red Algae Used In Clinique’s Smart Custom-Repair Serum 

    cliniqueAugust 26, 2014 | Following five years of research and development, the cosmetic company Clinique has announced that the major active ingredient in their Smart Custom-Repair Serum is Israeli red algae. The new serum has 37 patents on its list of ingredients, in which Israel’s red algae sits at the top. The product sells for $50 per 50 milliliters in the US, claiming to fight the oxidative effects of aging by targeting the areas that need it most. According to Clinique and following trials of the product, women reported a “noticeable improvement in the treatment of uneven skin tone, dark spots, dull-looking skin, fine lines and wrinkles and firming.”

  • mayay 3:47 pm on August 26, 2014 Permalink
    Tags: country r&d spending, economy news, israel r&d, israel research and development, , national spending r&d,   

    National Spending On Research & Development Down 1.3 Percent In 2013 

    economyAugust 26, 2014 | According to a report by “The Marker,” the national Israeli investment in research and development slowed in 2013, when compared to 2012 by 1.3 percent. In 2013, national spending on research and development in the high tech sector totaled NIS 44.2 billion, 83 percent of which was from the business sector and the remaining amount from academic and governmental institutions. The data is important because national spending records are often consulted by foreign investors.

  • mayay 3:26 pm on August 26, 2014 Permalink
    Tags: , comverse employment, comverse firing, comverse israel, , , telecommunications solutions   

    Comverse To Fire Hundreds Of Employees In Israel, Aboard 

    comverseAugust 26, 2014 | According to a report by “Calcalist,” the Israeli telecommunications software company Comverse will fire nearly 200 workers as part of a global firing round. The company, which is traded on NASDAQ, had 2,500 employees, 900 of them from Israel, as of January 31, 2014. The recent round of lay offs is the result of company losses in the year’s first financial quarter. Comverse was incorporation in 1997 as part of Comverse Technology.

  • mayay 3:07 pm on August 26, 2014 Permalink
    Tags: blood cancer treatments, , immune system blood cancer treatments, immune system cancer treatments, , kite pharma, kite pharma blood cancer treatments, kite pharma shares   

    Kite Pharma’s Shares Surge Following Positive Cancer Drug Test Results 

    kitepharmaAugust 26, 2014 | Following positive results in testing of Kite Pharma‘s cancer drug, the company’s shares surged 29 percent to $28.70 per share in after-hours trading. The results of the study on 15 patients with aggressive non-Hodgkin’s lymphoma, or blood cancer, were very positive, with 8 patients in complete remission and four others in partial remission. The company now plans to file and investigational new drug application in order to launch the clinical trail of the drug KTE-C19 for the treatment of blood cancers. The current trial was conducted by Kite Pharma and funded in part by the National Cancer Institute of America. Kite Pharma was founded in 2009 by Arie Belldegrun, an Israeli-American oncologist, specializing in developing therapies that use the patient’s immune system to treat cancer.

  • mayay 2:49 pm on August 26, 2014 Permalink
    Tags: elron dividend, elron electronic industries, elron shareholders, elron technology holding, ,   

    Elron To Distribute $110M Dividend To Shareholders 

    elronlogoAugust 26, 2014 | According to a “Globes” report, Elron Electronic Industries, which is controlled by IDB Group, announced that it will be distributing a $110 million dividend to its shareholders. Elron has notified the Tel Aviv Stock Exchange that it will distribute the dividend at $3.70 a share, following a decision by the company’s board on Sunday. Elron clarified that the dividend to be distributed is based on surpluses the company has amassed over the past two years, since their last dividend. Elron is a technology holding company founded in 1962 by Uzia Galil.

  • mayay 1:23 pm on August 26, 2014 Permalink
    Tags: gettaxi competition, israel rideshare services, taxis israel, uber israel, uber rideshare   

    Uber Rideshare Service Launches In Israel 

    uberAugust 26, 2014 | Uber, a US-based taxi-hailing company, officially launched its services today (Tuesday) in Israel. The Uber rideshare service is based on an application that allows users to call up a private driver or cab service and has already launched with success in a dozen different cities around the world. In Israel, Uber’s services will be launched as uberTAXI, similar to the current Israeli service GetTaxi that allows users to order cabs with the touch of a button (on their smartphone). Uber has already announced that it will allow its drivers to work with GetTaxi’s system, and vice versa. Uber is an American company worth nearly $10 billion, considered one of the largest privately-held Internet companies on the market.

  • mayay 1:02 pm on August 25, 2014 Permalink
    Tags: nielsen, nielsen israel, pereg ventures, pereg ventures israel, , venture capital israel   

    Report: Pereg Ventures Raises $25M From Nielsen and Tata 

    peregventuresAugust 25, 2014 | According to a report in “Calcalist,” Indian conglomerate group Tata and American company Nielsen invested $25 million in Pereg Ventures. Nielsen, a global information and measurement company, owns 51 percent of the Israeli venture capital firm and gave $10 million to the VC this round. Tata and other American investors also contributed to the $25 million sum that the Israel VC raised. This is the first round conducted by the VC, that hopes to raise between $50-100 million in total. Pereg Ventures is managed by Ziv Ben Baruch in Israel and two other partners in New York, focusing on post-seed to Series B companies in the United States and Israel.

  • mayay 12:40 pm on August 25, 2014 Permalink
    Tags: , ceragon communications solutions, ceragon shares, israel communications solutions, , over-allotment, , , underwriting   

    Ceragon Closes Over Allotment Option, Underwriters Spend $5.7M On Shares 

    Ceragon To Raise $35M On NasdaqAugust 25, 2014 | The underwriters on the secondary offering for Ceragon Networks spent $5.7 million to increase the proceeds from the offering to $45.1 million for the company. Ceragon is listed on NASDAQ and the Tel Aviv Stock Exchange at a $158 million market cap. The underwriters, Needham and Oppenheimer bought up close up to 2.9 million shares, with each share valued at $2.10. Ceragon, a provider of high-capacity wireless communications solutions, stated that the company needed more money in order to fulfill the orders coming in and to expand the company’s current projects. Ceragon was founded in 1996 and is headquartered in Tel Aviv.

  • mayay 4:04 pm on August 24, 2014 Permalink
    Tags: , email marketing tools, email newletter tools, godaddy, mad mimi, mad mimi israel startup, mail marketing service, tracking email newsletters   

    GoDaddy Acquires Email Marketing Service Mad Mimi 

    madmimiAugust 24, 2014 | GoDaddy acquired Mad Mimi, an email marketing tool that tracks the way people create, share and send email newsletters online. GoDaddy is a major web hosting service that hopes to Mad Mimi’s service to provide its small business customers with mail marketing tools. While the terms of the deal were not yet released, Mad Mimi has very little in terms of investments and funding, although the company was profitable upon acquisition. Mad Mimi was founded by South African-born Israeli Gary Levitt in 2007 and is headquartered in Brooklyn, New York.

  • mayay 3:44 pm on August 24, 2014 Permalink
    Tags: , , michael j. fox parkinsons research, , parkinsons research israel, parkinsons treatment, treatment for parkinson's disease, wearable parkinsons treatments   

    NeuroDerm Raises $16M For Wearable Parkinson’s Treatment 

    Neuroderm Raising $5M For Transdermal Drug Delivery System TrialAugust 24, 2014 | Israeli biotechnology company NeuroDerm raised $16 million in investments to continue working on its wearable treatment for Parkinson’s disease. The financing round was led by existing investors. The company is currently in the midst of a mid-stage study for its treatment for neurodegenerative disease, a belt pump that is worn around the waist and continuously administers Parkinson’s drugs for the most severe cases. The company and the testing of their Phase II treatment received a $1 million from the Michael J. Fox Foundation for Parkinson’s Research.

compose new post
next post/next comment
previous post/previous comment
show/hide comments
go to top
go to login
show/hide help
shift + esc